These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 1670369)

  • 1. [Insulin therapy in adult-onset diabetes].
    Taskinen MR
    Duodecim; 1990; 106(9):766-73. PubMed ID: 1670369
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of hyperglycemia in adult-onset diabetes mellitus].
    Yki-Järvinen H
    Duodecim; 1999; 115(10):1155-64. PubMed ID: 11877855
    [No Abstract]   [Full Text] [Related]  

  • 3. Circadian variations in plasma immunoreactive insulin (IRI) and C-peptide concentrations in adult onset (type II) diabetes mellitus.
    Nicolau GY; Haus E; Lakatua DJ; Bogdan C; Petrescu E; Sackett-Lundeen L; Stelea S; Stelea P
    Endocrinologie; 1984; 22(1):3-16. PubMed ID: 6369501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of exogenous insulin on C-peptide levels in subjects with type 2 diabetes.
    Albareda M; Rigla M; Rodríguez-Espinosa J; Caballero A; Chico A; Cabezas R; Carreras G; Pérez A
    Diabetes Res Clin Pract; 2005 Jun; 68(3):202-6. PubMed ID: 15936461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Insulin in the diabetic heart patient, only the glycemic results count].
    Fredenrich A
    Soins; 2006 Mar; (703 Suppl 1):1S18-20. PubMed ID: 16604812
    [No Abstract]   [Full Text] [Related]  

  • 6. [Metabolic control by means of insulin in patients with type 2 diabetes and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity--secondary publication].
    Gustafsson I; Malmberg K; Rydén L; Wedel H; Birkeland K; Bootsma A; Dickstein K; Efendic S; Fisher M; Hamsten A; Herlitz J; Hildebrandt PR; MacLeod K; Laakso M; Torp-Pedersen CT; Waldenström A;
    Ugeskr Laeger; 2006 Feb; 168(6):581-4. PubMed ID: 16476220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of glycaemic control and the introduction of insulin therapy on retinopathy in non-insulin-dependent diabetes mellitus.
    Stratton IM; Matthews DR
    Diabet Med; 1997 Aug; 14(8):709-10. PubMed ID: 9272603
    [No Abstract]   [Full Text] [Related]  

  • 8. Insulin therapy for type 2 diabetes.
    Pergallo-Dittko V
    Diabetes Self Manag; 2003; 20(5):17, 21, 23-4. PubMed ID: 14679948
    [No Abstract]   [Full Text] [Related]  

  • 9. Insulin requirement after one year of insulin therapy in type 2 diabetic patients dependent on fasting C-peptide.
    Biesenbach G; Bodlaj G; Pieringer H; Raml A
    Neth J Med; 2008 Jun; 66(6):259-60. PubMed ID: 18689911
    [No Abstract]   [Full Text] [Related]  

  • 10. Insulin and oral hypoglycemic agents should not be used in combination in the treatment of type 2 diabetes.
    Westphal SA; Palumbo PJ
    Arch Intern Med; 2003 Aug 11-25; 163(15):1783-5; discussion 1785. PubMed ID: 12912711
    [No Abstract]   [Full Text] [Related]  

  • 11. Intensive insulin treatment after acute myocardial infarction in diabetes mellitus. Evidence exists from study of non-insulin dependent diabetes in Japan.
    Williams R
    BMJ; 1997 Aug; 315(7107):544. PubMed ID: 9329313
    [No Abstract]   [Full Text] [Related]  

  • 12. [C-peptide determination in diabetics for the evaluation of insulin requirements].
    Keller U; Pasquel M; Berger W
    Schweiz Med Wochenschr; 1987 Feb; 117(6):187-92. PubMed ID: 3551060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Insulin treatment of Type II diabetes].
    Berger W; Waeber C; Tatti V
    Schweiz Rundsch Med Prax; 1990 Oct; 79(41):1233-6. PubMed ID: 2237054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucagon-induced plasma C-peptide response in diabetic patients. Influence of body weight and relationship to insulin requirement.
    Scheen AJ; Castillo MJ; Lefèbvre PJ
    Diabetes Metab; 1996 Dec; 22(6):455-8. PubMed ID: 8985655
    [No Abstract]   [Full Text] [Related]  

  • 15. Initiating insulin in type 2 diabetes.
    Ravina A
    Isr Med Assoc J; 2004 Dec; 6(12):787. PubMed ID: 15609901
    [No Abstract]   [Full Text] [Related]  

  • 16. Efficacy of insulin and sulfonylurea combination therapy in type II diabetes. A meta-analysis of the randomized placebo-controlled trials.
    Johnson JL; Wolf SL; Kabadi UM
    Arch Intern Med; 1996 Feb; 156(3):259-64. PubMed ID: 8572835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sulfonylureas and mortality in diabetic patients after myocardial infarction.
    Brady PA; Al-Suwaidi J; Kopecky SL; Terzic A
    Circulation; 1998 Feb; 97(7):709-10. PubMed ID: 9495313
    [No Abstract]   [Full Text] [Related]  

  • 18. Insulin as a first-line therapy in type 2 diabetes: should the use of sulfonylureas be halted?
    Standl E; Schnell O
    Diabetes Care; 2008 Feb; 31 Suppl 2():S136-9. PubMed ID: 18227474
    [No Abstract]   [Full Text] [Related]  

  • 19. Beneficial effects of insulin on endothelial function, inflammation, and atherogenesis and their implications.
    Kuritzky L; Nelson SE
    J Fam Pract; 2005 Jun; 54(6):S7-9. PubMed ID: 16021783
    [No Abstract]   [Full Text] [Related]  

  • 20. [Insulin therapy in type 2 diabetes: short-acting insulin analog has advantages].
    MMW Fortschr Med; 2006 Jun; 148(26):56-7. PubMed ID: 16875384
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.